Related Experiment Videos
Brain metastases from colon cancer
Journal of Neuro-Oncology
|January 1, 1983
Summary
Brain metastases from colon cancer are rare but carry a poor prognosis. Survival is limited regardless of treatment, with surgery offering slightly longer median survival than radiation therapy or chemotherapy.
Area of Science:
- Oncology
- Neurology
- Gastroenterology
Background:
- Brain metastases are a significant complication of advanced colon cancer.
- Identifying patients with brain metastases prior to neurological symptoms is challenging.
Purpose of the Study:
- To evaluate the incidence, clinical characteristics, and outcomes of patients with brain metastases from colon cancer.
- To compare the efficacy of different treatment modalities for brain metastases in colon cancer patients.
Main Methods:
- Retrospective analysis of 40 patients diagnosed with brain metastases from colon cancer between 1977 and 1980.
- Data collected on tumor location, metastatic spread, and treatment received (radiation therapy, surgery, chemotherapy).
- Survival analysis based on treatment modality.
Main Results:
- Brain metastases were diagnosed in 4% of colon cancer patients, typically after the initial cancer diagnosis.
- Most patients had extensive systemic disease and lymph node involvement at the time of brain metastasis diagnosis.
- Median survival was 9 weeks for radiation therapy, 37 weeks for surgery, and 4 weeks for chemotherapy.
- Tumor recurrence was common, with a median time of 4 months.
Conclusions:
- Brain metastases from colon cancer are associated with a poor prognosis.
- Surgical resection may offer a survival benefit compared to radiation therapy or chemotherapy.
- Further research is needed to improve outcomes for these patients.